Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Enrollment completed in phase IIa study of Serodus' SER-150

Nov. 28, 2016

No Comments

RGC upregulation may have a pathogenic role in lupus nephritis

Nov. 24, 2016

No Comments

Rayaldee set for U.S. launch

Nov. 24, 2016

No Comments

LPA receptor 1 as a target for diabetic nephropathy

Nov. 24, 2016

No Comments

Taisho Pharmaceutical's TP-0463518 in clinical development for renal anemia

Nov. 23, 2016

No Comments

Regulus chemically modified oligonucleotide for Alport syndrome

Nov. 22, 2016

No Comments

Sandoz's epoetin alfa biosimilar for renal anemia

Nov. 22, 2016

No Comments

Pan-Nox inhibitor for diabetic nephropathy

Nov. 22, 2016

No Comments

Laboratoris Sanifit reports clinical data on SNF-472

Nov. 21, 2016

No Comments

Apricus plans for Vitaros NDA resubmission next year

Nov. 21, 2016

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Urology
RSS

Enrollment completed in phase IIa study of Serodus' SER-150

RGC upregulation may have a pathogenic role in lupus nephritis

Rayaldee set for U.S. launch

LPA receptor 1 as a target for diabetic nephropathy

Taisho Pharmaceutical's TP-0463518 in clinical development for renal anemia

Regulus chemically modified oligonucleotide for Alport syndrome

Sandoz's epoetin alfa biosimilar for renal anemia

Pan-Nox inhibitor for diabetic nephropathy

Laboratoris Sanifit reports clinical data on SNF-472

Apricus plans for Vitaros NDA resubmission next year

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Urology RSS

Urology
RSS